Global Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems Market Report 2020-2025 with Profiles of Bristol-Myers Squibb Co., GSK, Hofmann-La Roche, Merck & Co., and Novartis
The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development, and drug delivery, and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections.
The report includes an analysis of leading and emerging drug products for each nanoparticle type. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products will alter the quality of life of patients receiving nanoparticle-associated drugs.
Nanoparticle technology has made major advances in particle type, production, and application in all areas of the life sciences in the past two decades. The most rapid advances have been made in the application of nanoparticles in drug research and development, drug product formulation, and development of novel drug delivery systems using nanoparticle carriers. The development of nanoparticles and their rapid incorporation into the research and development, formulation, and production of drug products has given rise to a new area of biotechnology and pharmaceutical research involving particle materials in the nanometer size range.
Nanoparticles used in the life sciences and biomedical applications are usually considered to be in the range of 10 nanometers to 100 nanometers in diameter. Developing particles from various starting materials that remain stable in this size range has become one of the fastest-growing and most potentially useful emerging technologies of the last several decades.
Both particle size and shape are important in the life sciences because the particle properties of biopharmaceutical products can impact a drug product in two ways: size and shape. Size and shape can have an influence on drug performance or efficacy in the body.
The methods for producing nanoparticles vary depending on the starting substrate materials and the size particle desired as a product. This report will provide an overview of various production methods and indicate new advances in the production area. At present, the U.S. holds the largest number of patents in the nanoparticle area. This is largely due to the early commercialization of some nanoparticle products by U.S. companies. It also reflects that the contribution to research and development of new ideas by American companies is larger than those by most other countries.
Europe is the second-largest market for nanoparticle drug technology. France, Germany, and the U.K. are the major contributors to its market share. Drug formulation and delivery are attracting new players in Europe, and this in turn will contribute to the market's growth.
The Report Includes:
43 tables
An overview of the global nanoparticles in biotechnology, drug development, and drug delivery market
Estimation of the market size and analyses of market trends, with data from 2019, estimates for 2020, and projection of CAGR through 2025
Highlights of the drug development, formulation, and the development of new drug delivery systems and detailed product analyses within health and wellness subsegments
Information on nanomedicine and biomedical nanoparticle products and coverage of the next-generation vaccines
Evaluation of current market trends, market size, market forecast, and detailed analysis of drivers, challenges, and opportunities affecting the market growth
Discussion on the role of nanotechnology in COVID-19 vaccine production, components, and methods in the vaccine design for COVID-19 and challenges for vaccine disruptions
Assessment of various approaches for the treatment of COVID-19, and detailed description of structure and penetration of coronavirus
Details of clinical trials of nanoparticle drugs and drug delivery systems
A look at the patents, licensing, mergers and acquisitions, and market share analysis of the key companies of the industry
Company profiles of major players including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Hofmann-La Roche Inc., Merck & Co., and Novartis AG
Key Topics Covered:
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Geographic Breakdown
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Introduction to Nanoparticles
Liposomes
Quantum Dots
Dendrimers
Macromolecule Nanoparticles
Brief History of Nanoparticles
Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Major Players in Nanoparticle Drug Delivery Field
Major Nanoparticle/Nanocrystal Drug Revenues
Chapter 4 Market Breakdown by Product Type
Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Distribution of Nanobiotechnology and Nanomedicine Companies
Chapter 5 Structure of Nanoparticles
Adoption of Nanoparticles in Applied Markets
Liquid Crystals
Liquid Carriers
Liposomes
Dendrimers
Chitosan and Alginate
Nanocrystals
Quantum Dots
Application of Nanoparticles to Drugs Delivered
Chapter 6 Production of Nanoparticles
Methods of Nanoparticle Formation
Self-Assembly Production
Methods of Stabilization
Methods of Drug Introduction
Polymeric Nanoparticles
Micelles
Liposomes
Gold and Silicon Nanoparticles
Dendrimers
Methods for Loading Biological Molecules into Nanoparticles
Nanocrystal Drugs
Problems with Large-Scale Nanoparticles Production
Chapter 7 Nanoparticles in Biotechnology
Research and Development
Stem Cell Research
Cellular Repair
Paramagnetic and Superparamagnetic Nanoparticles
Biosensors and Quantum Dots
Nanoparticle Research Collaborative Programs
Chapter 8 Nanoparticles in Drug Development and Formulation
Bio Separations
Rapid Drug Analysis
Removal of Impurities and Toxins
Using Nanoparticles to Incorporate Insoluble Drugs
Gold and Silver Nanoparticles in Biomedicine
DNA Nanoparticle Development of DNA-Specific Drugs
Chapter 9 Nanoparticles in Drug Delivery Systems
Nanoparticles in Drug Delivery Applications
Designing a Nanoparticle Drug Delivery System
Nanoparticle Drug Stability
Size Homogeneity of Nanoparticle Preparations
Drug Loading of Nanoparticles
Drug Release from Nanoparticles
External Triggers for Releasing Drugs from Nanoparticles
Binding/Incorporation of Biomolecules to Nanoparticles
Nanoparticle Toxicity
Large Scale Manufacturing
Methods of Administration of Nanoparticle Drugs
Oral Administration
Injection Administration
Transdermal Patch
Implantation Administration
Inhalation Administration
Nanoparticles Suitable for Drug Delivery Systems
Lipid-Based Nanoparticles
Micelle Nanoparticles
Dendrimer Nanoparticles
Polymeric Nanoparticles
Metal-Based Nanoparticles
Biological Macromolecule Nanoparticles
Nanocrystals
Nanoparticle Drug Delivery Systems Now Available
Antibiotic Nanoparticles
Anti-Tumor and Small Molecule Delivery by Nanoparticle
Release of Anti-Cancer Drugs from Nanoparticles
Biomacromolecules Delivered by Nanoparticles
Nanoparticles Coating for Drug Delivery Systems
Removal of Nanoparticles from the body
Chapter 10 In Vitro and In Vivo Diagnostic Imaging
In Vitro Imaging
Nanoparticles in Diagnostic Imaging
Chapter 11 Biomedical Nanoparticle Products
Nanoparticle Drug Delivery Systems and Products
Major Players in Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
Drivers of Nanoparticle Products and Marketing
Limiters of Nanoparticle Product Development and Marketing
Chapter 12 Market Breakdown by Region
Market Overview and Discussion
North America
Europe
Asia-Pacific
Rest of the World
South America
Middle East and Africa
Chapter 13 Role of Nanotechnology in COVID-19 Vaccine Production
Introduction
Novel Coronavirus Relying on Various Approaches
Structure of COVID-19 and Penetration
Challenges for COVID-19 Vaccines
Components and Methods in the Design of Vaccines
Antigen
Adjuvant
Nanoparticle/Nanocarrier
Device
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusion on Nanotechnology Usage Against COVID-19
Chapter 14 Patents, Licensing, Mergers, and Acquisitions
Recent Licensed, Mergers and Acquisition
Recent Licensing Activity, Mergers and Acquisition
About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...
YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and...
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...